African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center

References

• Mangold AR, Thompson AK, Davis MD, et al. Early clinical manifestations of Sézary syndrome: a multicenter retrospective cohort study. J Am Acad Dermatol. 2017;77(4):719–727.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Abbade LP, Marques ME, et al. Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update. An Bras Dermatol. 2012;87(6):817–828; quiz 829–830.
   PubMed Web of Science ®Google Scholar
• Vakiti A, Padala SA, Singh D. Sezary syndrome. Treasure Island (FL): StatPearls; 2020.
   Google Scholar
• Pulitzer MP, Horna P, Almeida J. Sezary syndrome and mycosis fungoides: an overview, including the role of immunophenotyping. Cytometry B Clin Cytom. 2021;100(2):132–138.
   PubMed Web of Science ®Google Scholar
• Al Hothali GI. Review of the treatment of mycosis fungoides and Sezary syndrome: a stage-based approach. Int J Health Sci. 2013;7(2):220–239.
   Google Scholar
• Whittaker S, Hoppe R, Prince HM. How I treat mycosis fungoides and Sézary syndrome. Blood. 2016;127(25):3142–3153.
   PubMed Web of Science ®Google Scholar
• Johnson WT, Kartan S, Sokol K, et al. Clinical characteristics and outcomes of black patients with mycosis fungoides and Sézary syndrome: a subgroup analysis of the phase III MAVORIC trial. Leuk Lymphoma. 2021 Aug; 62(8):1877–1883.
   PubMedGoogle Scholar
• Geller S, Lebowitz E, Pulitzer MP, et al. Outcomes and prognostic factors in African American and Black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol. 2020;83(2):430–439.
   PubMed Web of Science ®Google Scholar
• Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29(18):2598–2607.
   PubMed Web of Science ®Google Scholar
• Campbell BA, Scarisbrick JJ, Kim YH, et al. Time to next treatment as a meaningful endpoint for trials of primary cutaneous lymphoma. Cancers. 2020;12(8):2311.
   Web of Science ®Google Scholar
• Geller S, Lebowitz E, Pulitzer M, et al. Understanding racial disparities in mycosis fungoides through international collaborative studies. Br J Dermatol. 2019;180(5):1263–1264.
   PubMed Web of Science ®Google Scholar
• Scarisbrick JJ, Quaglino P, Prince HM, et al. Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease. Br J Dermatol. 2019;180(5):1264–1265.
   PubMed Web of Science ®Google Scholar
• Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013;149(11):1295–1299.
   PubMed Web of Science ®Google Scholar
• Kaufman AE, Patel K, Goyal K, et al. Mycosis fungoides: developments in incidence, treatment and survival. J Eur Acad Dermatol Venereol. 2020;34(10):2288–2294.
   PubMed Web of Science ®Google Scholar
• Gao C, McCormack C, van der Weyden C, et al. Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sezary syndrome. Blood. 2019;134(16):1346–1350.
   PubMed Web of Science ®Google Scholar
• Hanel W, Briski R, Ross CW, et al. A retrospective comparative outcome analysis following systemic therapy in mycosis fungoides and Sezary syndrome. Am J Hematol. 2016;91(12):E491–E495.
   PubMed Web of Science ®Google Scholar
• Huang AH, Kwatra SG, Khanna R, et al. Racial disparities in the clinical presentation and prognosis of patients with mycosis fungoides. J Natl Med Assoc. 2019;111(6):633–639.
   PubMed Web of Science ®Google Scholar
• Wilson WH, Jung SH, Porcu P, et al. A cancer and leukemia group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 2012;97(5):758–765.
   PubMed Web of Science ®Google Scholar
• Lim E, Miyamura J, Chen JJ. Racial/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, Blacks, Hispanics, and White. Hawaii J Med Public Health. 2015;74(9):302–310.
   PubMedGoogle Scholar
• Immunoblastic lymphadenopathy: report of 11 cases. Chin Med J. 1980;93(11):767–772.
   PubMed Web of Science ®Google Scholar
• Nath SK, Yu JB, Wilson LD. Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008. Clin Lymphoma Myeloma Leuk. 2014;14(5):419–423.
   PubMed Web of Science ®Google Scholar
• Imam MH, Shenoy PJ, Flowers CR, et al. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma. 2013;54(4):752–759.
   PubMed Web of Science ®Google Scholar
• Allen PB, Flowers C, Lechowicz MJ, et al. Association of insurance status and race with overall survival among patients with cutaneous T-cell lymphoma: a national cancer database analysis. J Clin Oncol. 2018;36(15_suppl):e18624.
   Web of Science ®Google Scholar
• Desai M, Liu S, Parker S. Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sézary syndrome in the southeastern United States: a single-institution cohort. J Am Acad Dermatol. 2015;72(2):276–285.
   PubMed Web of Science ®Google Scholar
• Kotkin JF. The cities where African-Americans are doing the best economically; 2018 [updated 2018 Jan 15; cited 2018 Oct 11]. Available from: https://www.forbes.com/sites/joelkotkin/2018/01/15/the-cities-where-african-americans-are-doing-the-best-economically-2018/#646768481abe
   Google Scholar
• Nielsen PR, Eriksen JO, Wehkamp U, et al. Clinical and histological characteristics of mycosis fungoides and Sézary syndrome: a retrospective, single-centre study of 43 patients from Eastern Denmark. Acta Derm Venereol. 2019;99(13):1231–1236.
   PubMed Web of Science ®Google Scholar
• Lebowitz E, Geller S, Flores E, et al. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. J Eur Acad Dermatol Venereol. 2019;33(1):108–114.
   PubMed Web of Science ®Google Scholar
• Knobler R, Berlin G, Calzavara-Pinton P, et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol. 2014;28 Suppl 1:1–37.
   PubMed Web of Science ®Google Scholar